Mixed Lanthanide Oxide Research Articles

An ultra-durable ZIT glass-ceramic composite for immobilization of radioactive mixed lanthanide oxides

Zinc Titanate (ZIT) glass-ceramic composite is a potential candidate waste form for immobilizing radioactive lanthanide oxides due to its relatively high lanthanide embedding capacity and low reaction temperature. However, the composition of lanthanide oxides after electrolytic refining is very complex and the immobilization mechanism of lanthanide oxides by ZIT composite is not clear. Herein, we prepared ZIT-PrEu glass-ceramic waste forms by a solid-phase sintering method at 1200 °C for 4 h using mixed lanthanide oxides of Pr6O11 and Eu2O3 simulated as radioactive waste. The XRD and SEM results show that different mixed lanthanide oxide ratios have very little effect on the composition and microstructure of ZIT-PrEu waste forms with different waste embedding rates. With the increase of waste embedding rate, the density of the ZIT-PrEu glass-ceramic waste forms with different mixed lanthanide oxide ratios first increases and then decreases. When the embedding rate increases to 25 wt%, the density of ZIT-PrEu waste forms with different mixed lanthanide oxide ratios reaches a maximum. The ZIT-PrEu glass-ceramic waste forms embedded with 25 wt% waste exhibit excellent chemical durability, and the leaching rates of Pr ion and Eu ion are only 10−6 - 10−7 g m−2 d−1 after 28 days at 90 °C. Moreover, the phase evolution of the ZIT composites immobilizing lanthanide oxides at different temperatures is revealed by XRD and FT-IR measurements. The lanthanides (Ln) are mainly present in the form of LnPO4 monazite phases.

Lithium carbonate-promoted mixed rare earth oxides as a generalized strategy for oxidative coupling of methane with exceptional yields

The oxidative coupling of methane to higher hydrocarbons offers a promising autothermal approach for direct methane conversion, but its progress has been hindered by yield limitations, high temperature requirements, and performance penalties at practical methane partial pressures (~1 atm). In this study, we report a class of Li2CO3-coated mixed rare earth oxides as highly effective redox catalysts for oxidative coupling of methane under a chemical looping scheme. This catalyst achieves a single-pass C2+ yield up to 30.6%, demonstrating stable performance at 700 °C and methane partial pressures up to 1.4 atm. In-situ characterizations and quantum chemistry calculations provide insights into the distinct roles of the mixed oxide core and Li2CO3 shell, as well as the interplay between the Pr oxidation state and active peroxide formation upon Li2CO3 coating. Furthermore, we establish a generalized correlation between Pr4+ content in the mixed lanthanide oxide and hydrocarbons yield, offering a valuable optimization strategy for this class of oxidative coupling of methane redox catalysts.

Mixed Lanthanide Oxide Nanoparticles Coated with Alginate-Polydopamine as Multifunctional Nanovehicles for Dual Modality: Targeted Imaging and Chemotherapy.

Integrating anticancer drugs and diagnostic agents in a polymer nanosystem is an emerging and promising strategy for improving cancer treatment. However, the development of multifunctional nanoparticles (NPs) for an "all-in-one" platform characterized by specific targeting, therapeutic efficiency, and imaging feedback remains an unmet clinical need. In this study, pH-responsive mixed-lanthanide-based multifunctional NPs were fabricated based on simple metal-ligand interactions for simultaneous cancer cell imaging and drug delivery. We investigated two new systems of alginate-polydopamine complexed with either terbium/europium or dysprosium/erbium oxide NPs (Tb/Eu@AlgPDA or Dy/Er@AlgPDA NPs). Tb/Eu@AlgPDA NPs were then functionalized with the tumor-targeting ligand folic acid (FA) and loaded with the anticancer drug doxorubicin (DOX) to form FA-Tb/Eu@AlgPDA-DOX NPs. Using such systems, the mussel-inspired property of PDA was introduced to improve tumor targetability and penetration, in addition to active targeting (via FA-folate receptor interactions). Determining the photoluminescence efficiency showed that the Tb/Eu@AlgPDA system was superior to the Dy/Er@AlgPDA system, presenting intense and sharp emission peaks on the fluorescence spectra. In addition, compared to Dy/Er@AlgPDA NPs (82.4%), Tb/Eu@AlgPDA NPs exhibited negligible cytotoxicity with >93.3% HeLa cell viability found in MTT assays at NP concentrations of up to 0.50 mg/mL and high biocompatibility when incubated with zebrafish (Danio rerio) embryos and larvae. The FA-Tb/Eu@AlgPDA-DOX system exhibited a pH-responsive and sustained drug-release pattern. In a spheroid model of HeLa cells, the FA-Tb/Eu@AlgPDA-DOX system showed a better penetration efficiency and spheroid growth-inhibitory effect than free DOX. After incubation with zebrafish embryos, the FA-Tb/Eu@AlgPDA-DOX system also showed improved antitumor efficacies versus the other experimental groups in HeLa tumor cell xenografted zebrafish. Therefore, our results suggested that FA-Tb/Eu@AlgPDA-DOX NPs are promising multifunctional nanocarriers with therapeutic capacity for tumor targeting and penetration.

Potential fluorescence and magnetic resonance imaging modality using mixed lanthanide oxide nanoparticles.

Imaging is a very important technique in the diagnosis and treatment of cancer diseases. This study developed a dual modality (fluorescence/MR) imaging technique for cancer cell lines (HeLa) and T2-weighted phantom imaging by using a mixed lanthanide (Dy/Er/Tb) oxide nanoparticles. To further enhance the solubility, stability and biocompatibility of mixed lanthanide oxide, the nanoparticles were coated with folic acid as well as G4.5 PAMAM dendrimer. The coated nanoparticles were then compared, the later with results demonstrating pronounced effects in both T2 weighted phantom MR and fluorescence imaging of the cancer cell lines. Imaging enhancement was attributed to a synergistic effect of the fluorescent properties and higher water solubility of the PAMAM dendrimer when compared to the folic acid. Besides, mixed lanthanides of Dy and Tb were used for T2 weighted MR imaging, while mixed lanthanides of Er and Tb were used for fluorescence imaging in the near infrared and visible regions, and were synthesized in the facile composition control. Hence, the mixed lanthanide oxides are packed together, and stable, which is used to facilitate biomedical imaging in vitro. To conclude, the G4.5 PAMAM dendrimer coated mixed lanthanide oxide nanoparticles will be used for dual-modality (fluorescence/MR imaging) cancer cell line detection in both in vitro and in vivo study.

Dual-mode T1 and T2 magnetic resonance imaging contrast agent based on ultrasmall mixed gadolinium-dysprosium oxide nanoparticles: synthesis, characterization, and in vivo application

A new type of dual-mode T1 and T2 magnetic resonance imaging (MRI) contrast agent based on mixed lanthanide oxide nanoparticles was synthesized. Gd3+ (8S7/2) plays an important role in T1 MRI contrast agents because of its large electron spin magnetic moment resulting from its seven unpaired 4f-electrons, and Dy3+ (6H15/2) has the potential to be used in T2 MRI contrast agents because of its very large total electron magnetic moment: among lanthanide oxide nanoparticles, Dy2O3 nanoparticles have the largest magnetic moments at room temperature. Using these properties of Gd3+ and Dy3+ and their oxide nanoparticles, ultrasmall mixed gadolinium-dysprosium oxide (GDO) nanoparticles were synthesized and their potential to act as a dual-mode T1 and T2 MRI contrast agent was investigated in vitro and in vivo. The D-glucuronic acid coated GDO nanoparticles (davg = 1.0 nm) showed large r1 and r2 values (r2/r1 ≈ 6.6) and as a result clear dose-dependent contrast enhancements in R1 and R2 map images. Finally, the dual-mode imaging capability of the nanoparticles was confirmed by obtaining in vivo T1 and T2 MR images.

Mixed lanthanide oxide nanoparticles as dual imaging agent in biomedicine

There is no doubt that the molecular imaging is an extremely important technique in diagnosing diseases. Dual imaging is emerging as a step forward in molecular imaging technique because it can provide us with more information useful for diagnosing diseases than single imaging. Therefore, diverse dual imaging modalities should be developed. Molecular imaging generally relies on imaging agents. Mixed lanthanide oxide nanoparticles could be valuable materials for dual magnetic resonance imaging (MRI)-fluorescent imaging (FI) because they have both excellent and diverse magnetic and fluorescent properties useful for dual MRI-FI, depending on lanthanide ions used. Since they are mixed nanoparticles, they are compact, robust, and stable, which is extremely useful for biomedical applications. They can be also easily synthesized with facile composition control. In this study, we explored three systems of ultrasmall mixed lanthanide (Dy/Eu, Ho/Eu, and Ho/Tb) oxide nanoparticles to demonstrate their usefulness as dual T2 MRI–FI agents.

Paramagnetic nanoparticle T1 and T2 MRI contrast agents

There is no doubt that magnetic resonance imaging contrast agents (MRI CAs) can play a vital role in diagnosing diseases. Therefore, demand for new MRI CAs with an enhanced sensitivity and advanced functionalities is very high. Here, paramagnetic nanoparticles (NPs) are reviewed as new potential candidates for either T(1) or T(2) MRI CAs or both. These include surface coated lanthanide (Ln) oxide NPs (Ln = Gd, Dy, and Ho) and manganese oxide NPs. Surface coating materials should be biocompatible and hydrophilic. Compared to conventional large NPs, these surface coated paramagnetic NPs can be made ultrasmall with core particle diameter ranging from 1 to 3 nm, but their magnetic properties are still sufficient for MRI CAs. At this particle diameter, they can be easily excreted from the body through the renal system, which is prerequisite for in vivo applications. Mixed lanthanide oxide NPs into which a fluorescent Ln material is incorporated will be valuable as multiple imaging agents for both MRI-fluorescent imaging (FI) and MRI-cellular imaging (CL). These paramagnetic NPs can be further functionalized towards target-specific imaging, multiplex imaging, and drug delivery.

Solid state reactions in highly dispersed single and mixed lanthanide oxide–SiO 2 systems

This paper summarizes our previous studies on the interaction of highly dispersed lanthanide oxides (La, Ce, Pr, Nd and Lu) with amorphous silica and presents new data on the Ce 0.5Yb 0.5O 1.75–SiO 2 system. It is shown that at temperatures above 800 °C, chemical reaction between lanthanide oxide and silica may occur leading to formation of silicate phases with unusual structure not observed for bulk like oxide–SiO 2 systems. For nano Ce 0.5Yb 0.5O 1.75–SiO 2 system results of TEM, SEM and XRD studies revealed that at or above 1000 °C, ytterbium is withdrawn from the mixed oxide and B-type polymorph of Yb 2Si 2O 7 (Yb 4[Si 3O 10][SiO 4]) is formed. This polymorph, till now known as high pressure form, is unstable at 1100 °C and transforms into ordinary C-type Yb 2Si 2O 7. Mechanism of silicate formation and its possible role in deactivation of supported catalysts containing lanthanide oxides as active phase or as promoters is discussed.

New ceria-based catalysts for pollution abatement

In the present work, we describe the use of fluorite-structured solid solutions, based on mixtures of CeO 2/La 2O 3/Pr 2O 3, and similar systems, i.e. CeO 2/Ln 2O 3/Pr 2O 3 where Ln=Tb, Sm, and Gd as effective catalysts for methane combustion. Mixed lanthanide oxide doped ceria solid solutions were prepared using an evaporation method from nitrate precursors and were subsequently calcined to 1073 K. Sample characterisation was achieved using powder X-ray diffraction (PXRD) and temperature programmed reduction (TPR). PXRDs obtained subsequent to a 12 h calcination at 1073 K for 12 h all show peaks corresponding to a fluorite-based structure. There are no additional features suggestive of large-scale segregation or ordered superstructure formation. This was confirmed by Rietveld analysis which showed that the lattice possesses cubic nature with a= b= c=5.50 Å. Methane combustion tests show that the most effective catalysts are those lanthanide oxide doped ceria catalysts prepared with 5% Pr molar metal ratios. TPR experiments suggest PrO 2 is an essential component and both surface and bulk chemistries have important roles in catalytic activity.

Laser ablation synthesis of lanthanide oxide clusters: Mechanisms and chemistry

Excimer laser ablation into vacuum of hydrated lanthanide oxalates has produced new lanthanide (Ln) oxide cluster ions which were identified by time-of-flight mass spectrometry. In addition to binary oxide clusters (LnmO+n), mixed lanthanide oxide clusters [Lnm1Lnm2′O+n with (m1+m2)≤9] were discerned for the following Ln-Ln′: La-Tb, La-Ho, La-Lu, and Ho-Lu. The observed cluster ion stoichiometries, abundance distributions, and hydration systematics provide insights into cluster formation mechanisms and chemistries. Time-variable ion sampling revealed cluster enhancement in the tail of the ablation plume. The body of experimental results support cluster formation by aggregation of small ablated species.